1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NOVO NORDISK - ADR
45.16 -1.44 (-3.09%)
10.3M
XNYS Volume

XNYS 08 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Pipeline Setback
Novo Nordisk falls as it halts two ziltivekimab heart-failure trials, hurting diversification plans See details


Insider Trading disclosures for Novo Nordisk (ADR)

There were no Insider Trade disclosures made for Novo Nordisk (ADR)

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures